Suchergebnisse - "Dass, Crispin R"

PubPharm (360)

101

Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities

enthalten in: Journal of pharmacy and pharmacology | 2016

von Wong, C. | Martinez, J. | Dass, C.

102

Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism

enthalten in: Journal of pharmacy and pharmacology | 2016

von Meredith, A. | Dass, C.

103

Pigment epithelium-derived factor stimulates skeletal muscle glycolytic activity through NADPH oxidase-dependent reactive oxygen species production

enthalten in: The international journal of biochemistry & cell biology | 2016

von Carnagarin, R. | Carlessi, R. | Newsholme, P. | +2

104

Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities

enthalten in: Journal of pharmacy and pharmacology | 2016

von Wong, C. | Martinez, J. | Dass, C.

105

Pigment epithelium-derived factor stimulates skeletal muscle glycolytic activity through NADPH oxidase-dependent reactive oxygen species production

enthalten in: The international journal of biochemistry & cell biology | 2016

von Carnagarin, R. | Carlessi, R. | Newsholme, P. | +2

106

Molecular aspects of glucose homeostasis in skeletal muscle--A focus on the molecular mechanisms of insulin resistance

enthalten in: Molecular and cellular endocrinology | 2015

von Carnagarin, R. | Dharmarajan, A. | Dass, C.

107

Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer

enthalten in: Carbohydrate polymers | 2015

von Manchun, S. | Dass, C. | Cheewatanakornkool, K. | +1

108

Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment : comparison with osteosarcoma cells

enthalten in: The Journal of pharmacy and pharmacology | 2015

von Tacar, O. | Indumathy, S. | Tan, M. | +3

109

PEDF-induced alteration of metabolism leading to insulin resistance

enthalten in: Molecular and cellular endocrinology | 2015

von Carnagarin, R. | Dharmarajan, A. | Dass, C.

110

Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis

enthalten in: The Journal of pharmacy and pharmacology | 2015

von Friedhuber, A. | Chandolu, V. | Manchun, S. | +3